mechanism 1,407 words KG: SASP
Contents

SASP (Senescence-Associated Secretory Phenotype) in Neurodegeneration

Mechanism Info
NameSASP
Key Genes/ProteinsCDKN2A, cxcl10, MTOR
Related DiseasesAlzheimer's Disease, Alzheimer'S Disease, Aβ-induced neurotoxicity, fibrosis, microglial senescence
Related PathwaysBDNF expression, MAPK
Linked Hypotheses40 hypotheses

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (149)

Tau-Independent Microtubule Stabilization via MAP6 Enhanceme
Score: 0.57
Astroglial Gap Junction Coordination via Connexin-43 Phospho
Score: 0.57
CX43 hemichannel engineering enables size-selective mitochon
Score: 0.57
Fractalkine Axis Amplification via CX3CR1 Positive Allosteri
Score: 0.56
Circadian-Gated Maresin Biosynthesis Amplification
Score: 0.56
Digital Twin-Guided Metabolic Reprogramming
Score: 0.55
Temporal Decoupling via Circadian Clock Reset
Score: 0.54
Lysosomal Membrane Repair Enhancement
Score: 0.54
Glymphatic System-Enhanced Antibody Clearance Reversal
Score: 0.54
Blood-Brain Barrier SPM Shuttle System
Score: 0.53
Gut Barrier Permeability-α-Synuclein Axis Modulation
Score: 0.53
Cryptic Exon Silencing Restoration
Score: 0.53
Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener
Score: 0.53
Piezoelectric Nanochannel BBB Disruption
Score: 0.52
Vocal Cord Neuroplasticity Stimulation
Score: 0.52
Microbial Metabolite-Mediated α-Synuclein Disaggregation
Score: 0.51
Enteric Nervous System Prion-Like Propagation Blockade
Score: 0.48
Microbiome-Derived Tryptophan Metabolite Neuroprotection
Score: 0.43
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.38
Targeted Butyrate Supplementation for Microglial Phenotype M
Score: 0.80
← Prevpg 7/8Next →

Related Analyses (30)

Senolytic therapy for age-related neurodegeneration
neurodegeneration · completed
Senescent cell clearance as neurodegeneration therapy
neurodegeneration · completed
Senescent cell clearance as neurodegeneration therapy
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived

Related Experiments (30)

Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer's
clinical · proposed · Score: 0.40
CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs
clinical · proposed · Score: 0.90
Vascular Contributions to Alzheimer Disease and Mixed Pathol
clinical · proposed · Score: 0.40
CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs
clinical · proposed · Score: 0.40
Viral and Post-Infectious Mechanisms in ALS — Experiment Des
clinical · proposed · Score: 0.40

See Also (15)

Beta-Propeller Protein-Associated Neurodegeneration (BP
disease · Pages share 139 hypotheses
China Neurodegeneration Epidemiology
disease · Pages share 139 hypotheses
Synaptic Biomarkers in Neurodegeneration
biomarker · Pages share 139 hypotheses
BEACoN Study - Biomarker Exploration in Aging, Cognitio
clinical · Pages share 139 hypotheses
Neuroimaging for Parkinsonian Syndromes (NCT03872102)
clinical · Pages share 27 hypotheses

Knowledge Graph (12 edges)

SASP activates fibrosis
SASP activates neuroinflammation
Senescent Microglia associated_with SASP
SASP expressed_in Senescent Microglia
Senescent Microglia expressed_in SASP
SASP mediates chronic inflammation
senescent cells develops SASP
SASP promotes chronic inflammation
SASP promotes tissue dysfunction
NFKB1 promotes SASP

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.